Russian Professional Development in HIV/AIDS Medicine
Managed By: Russia
Initial Year: 2007
Final Year: 2009
USAID Contact: Olga Frolova
Alliance Location: ENE Regional
Program Objective: This public-private partnership aims to train a cadre of health care professionals in state-of-the-art HIV/AIDS treatment and care so that they can serve as experts and leaders in the field.
American International Health Alliance (AIHA)
This partnership brings the global pharmaceutical company Glaxo-Smith-Kline (GSK) together with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to further the professional development of Russian medical specialists in regions most affected by the HIV/AIDS epidemic. Under the project, a core group of clinical leaders will be trained through an intensive two-year fellowship program that will significantly enhance their clinical expertise in HIV medicine.
Participants in the fellowship program are selected based on their qualifications and potential to become future leading authorities in the HIV/AIDS field. In particular, their ability and will to educate others—to provide peers with the knowledge and advice needed to build the overall capacity of the Russian HIV-related medical sector—is considered.
The project will use an interactive Russian-language Web portal, developed under the EurasiaHealth project, to allow medical professionals to share best practices and to access a library of the latest resources, including treatment guidelines and protocols, textbooks, training materials, and clinical case studies.
GlaxoSmithKline and the implementing partner, the American International Health Alliance (AIHA), selected 18 outstanding HIV professionals on a competitive basis to form the core group of experts.
As of July 2008, two training workshops had been conducted and the web site had become operational. In addition, AIHA piloted a six-week distance learning course during which 5 clinical case studies were actively discussed online by the selected professionals.